NCT02076724

Brief Summary

The purpose of this study is to compare two methods for reinforcement of the abdominal donor-site after breast reconstruction with the pedicled TRAM-flap. Reinforcement of the abdominal donor-site is performed, after randomization, with either a porcine derived biological mesh or a synthetic mesh. The patient and the investigator is blinded. The aim is to identify the most optimal method for reinforcement of the abdominal donor-site and thereby contribute to fast and complete rehabilitation of women undergoing breast reconstruction with the pedicled TRAM-flap after surgical removal of the breast tissue due to breast cancer, precursors to breast cancer or an increased risk of developing breast cancer and thereby following preventive removal of the breast tissue. The patients visit the outpatient clinic 4, 12 and 24 months after operation and abdominal wall function, the donor site morbidity, the frequency of postoperative complications, the aesthetic appearance of the reconstructed breast and the abdominal wall and costs are evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2014

Completed
3 days until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2014

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

January 9, 2020

Status Verified

January 1, 2020

Enrollment Period

4.8 years

First QC Date

February 26, 2014

Last Update Submit

January 6, 2020

Conditions

Keywords

Abdominal donor-siteBreast reconstructionSynthetic meshBiological mesh

Outcome Measures

Primary Outcomes (1)

  • Abdominal wall function change

    Strength of abdominal wall is assessed by a standardized physical examination developed in collaboration with physiotherapists. A dynamometer is used to get an exact value of muscle strength.

    Change from before surgery to 12 and 24 months after surgery

Secondary Outcomes (4)

  • Abdominal donor site morbidity

    24 months

  • Aesthetics at the abdominal wall

    24 months

  • Costs

    24 months

  • Postoperative complications

    Acute <1 month, ≥ 1 month-24 months

Study Arms (2)

Biological mesh (Strattice Firm)

EXPERIMENTAL

Strattice Firm is inserted using inlay technique as reinforcement of the abdominal wall where the anterior rectus fascia has been excised.

Device: Biological mesh

Synthetic mesh (Prolene)

EXPERIMENTAL

Prolene mesh is inserted using inlay technique as reinforcement of the abdominal wall where the anterior rectus fascia has been excised.

Device: Synthetic mesh

Interventions

Also known as: Strattice Reconstructive Tissue Matrix Firm, LifeCell Corp.
Biological mesh (Strattice Firm)
Also known as: Prolene mesh, Ethicon
Synthetic mesh (Prolene)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Immediate or delayed breast reconstruction using the pedicled TRAM-flap
  • Older than 18 years of age
  • Understand enough Danish to comprehend the given information and to complete the study questionnaire
  • Verbal and written informed consent

You may not qualify if:

  • Current smokers
  • Not eligible patients, assessed by surgeon
  • High level of co-morbidity, assessed by surgeon or anesthesiologist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic and Reconstructive Surgery, Aarhus University Hospital

Aarhus C, Aarhus, 8000, Denmark

Location

Study Officials

  • Mette Eline Brunbjerg, MD

    Aarhus University Hospital and Aarhus University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 26, 2014

First Posted

March 4, 2014

Study Start

March 1, 2014

Primary Completion

January 1, 2019

Study Completion

March 1, 2019

Last Updated

January 9, 2020

Record last verified: 2020-01

Locations